Literature DB >> 11168126

Pharmacodynamics of doxycycline.

B A Cunha1, P Domenico, C B Cunha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11168126     DOI: 10.1046/j.1469-0691.2000.00058-2.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  23 in total

1.  An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

Review 2.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

3.  Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data.

Authors:  Ashley M Hopkins; Jessica Wojciechowski; Ahmad Y Abuhelwa; Stuart Mudge; Richard N Upton; David J R Foster
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.

Authors:  Jay-Hyun Jo; Catriona P Harkins; Nicole H Schwardt; Jessica A Portillo; Matthew D Zimmerman; Claire L Carter; Md Amir Hossen; Cody J Peer; Eric C Polley; Véronique Dartois; William D Figg; Niki M Moutsopoulos; Julia A Segre; Heidi H Kong
Journal:  Sci Transl Med       Date:  2021-12-22       Impact factor: 17.956

5.  Bioerodible system for sequential release of multiple drugs.

Authors:  Sharath C Sundararaj; Mark V Thomas; Thomas D Dziubla; David A Puleo
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

Review 6.  The glycylcyclines: a comparative review with the tetracyclines.

Authors:  George G Zhanel; Kristen Homenuik; Kim Nichol; Ayman Noreddin; Lavern Vercaigne; John Embil; Alfred Gin; James A Karlowsky; Daryl J Hoban
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.

Authors:  Marit Gaastra Maaland; Mark G Papich; John Turnidge; Luca Guardabassi
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

8.  Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.

Authors:  Karen E Bowker; Alan R Noel; Alasdair P Macgowan
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

9.  Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy.

Authors:  Natasha F Cover; Susana Lai-Yuen; Anna K Parsons; Arun Kumar
Journal:  Int J Nanomedicine       Date:  2012-06-25

10.  Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.

Authors:  Erdal Erol; Mariela Scortti; Jordan Fortner; Mukesh Patel; José A Vázquez-Boland
Journal:  J Clin Microbiol       Date:  2021-07-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.